Cost-effectiveness of molecular diagnostic assays for the therapy of severe sepsis and septic shock in the emergency department.
Ioannis M ZacharioudakisFainareti N ZervouFadi ShehadehEleftherios MylonakisPublished in: PloS one (2019)
The incorporation of molecular tests in the management of sepsis in the ED has the potential to improve outcomes and be cost-effective for a wide range of clinical scenarios.